Abstract:90% of spine tumor patients can develop metastases with debilitating complications, such as sensorimotor dysfunction, paralysis, and spinal instability. As spine tumor patients have limited eligibility to participate in clinical trials and have heterogenous tumor pathology, there is a distinct lack of therapeutic targets and prognostication markers of disease. Thus, there is a distinct need for molecular profiling of spine tumors. We describe an OR-to-bench-top processing of spine tumors for single-cell omic studies, with samples from a metastatic prostate cancer patient to demonstrate the ability to compare molecular markers and microenvironments of difficult-to-process spine tumors and adjacent normal tissue. Under IRB protocol #Pro00101198, patients undergoing spine surgery with the Department of Neurosurgery at Duke University were consented for tissue collection. Vertebral osseous metastases and adjacent normal tissue were confirmed histologically (H&E, immunohistochemistry) and radiologically (MRI, PET, CT, and x-ray). Tissues were manually and enzymatically homogenized in serum-free media with collagenase A and DNAse I to obtain a single cell suspension. Cells were then filter sterilized, erythrolyzed, counted to determine live-death ratio, resuspended to 10-20 million cells per mL, then cryopreserved for downstream standard library preparation for single-cell sequencing using the 10X genomics platform. Downstream analysis was performed using Seurat pipeline, InferCNV analysis, and SingleR. P404S and PSA expression confirmed tumor was prostate in origin. Radiological imaging and H&E staining confirmed the presence of T7 osseous metastasis. Uniform manifold approximation and project (UMAP) plots identified 12 unique clusters of immune cell subpopulations between normal and tumorous vertebrae, with their own subsets of differentially expressed genes. We have developed a protocol to generate granular single cell molecular profiling for spine tumors and metastases. Applications of this protocol can aid in identifying therapeutic targets, molecular predictors of disease, and potentiate increased eligibility of patients for clinical trials.

Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors

The Impact of Adjunct Medical Therapy on Survival after Spine Metastasis: A Systematic Review and Pooled Data Analysis

Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival

Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases

Radiotherapy and Surgical Advances in the Treatment of Metastatic Spine Tumors: A Narrative Review

Biomaterials-enhanced Bioactive Agents to Efficiently Block Spinal Metastases of Cancers.

Spine Oncology - Primary Spine Tumors

Current and Emerging Approaches for Spine Tumor Treatment

Global trends in the utilisation of NOMS framework for spinal metastasis management: A systematic review

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment

Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility

The surgical treatment of metastatic spine tumors within the intramedullary compartment

Predictive Modeling for Spinal Metastatic Disease

Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer

Molecular Foundations of Primary Spinal Tumors-Implications for Surgical Management.

Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy

Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma

Molecular foundations of primary spinal tumors—implications for surgical management

Biom-04. Single-Cell Rna Sequencing Protocol Of The Human Metastatic Prostate Spine Tumor Microenvironment

Streamlining the Journey of Research Into Clinical Practice: Making Your Patients and Practice Flourish Understanding and Setting Treatment Expectations for Patients With Metastatic Spine Tumors

The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy